Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between December 24, 2012, and December 26, 2012. The filing details the completion of a secondary offering of common stock and the full exercise of an underwriters' option to purchase additional shares.
Key Financial Metrics
- Total Net Proceeds to Acadia: Approximately $173.0 million.
- Proceeds from Option Exercise: Approximately $22.7 million.
- Public Offering Price: $22.50 per share.
- Total Shares Sold: 12,159,776 shares (10,576,623 Firm Shares + 1,583,153 Option Shares).
- Proceeds to Selling Stockholders: Acadia received no proceeds from the sale of shares by Selling Stockholders.
Material Changes and Events
On December 19, 2012, underwriters exercised their option to purchase all 1,583,153 Option Shares. The sale of these shares was completed on December 24, 2012. This event increased the total capital raised from the offering beyond the initial firm commitment.
Management Commentary and Use of Proceeds
Management intends to use the net proceeds principally to fund its acquisition strategy, specifically targeting the planned acquisitions of Behavioral Centers of America, LLC and AmiCare Behavioral Centers, LLC. Remaining funds may be used for general corporate purposes, including the potential repayment of debt under the company's senior secured credit facility.
Investor Verification Checklist
- Verify the closing status and integration plans for the acquisitions of Behavioral Centers of America, LLC and AmiCare Behavioral Centers, LLC.
- Confirm the exact amount of debt repayment, if any, executed against the senior secured credit facility using these proceeds.
- Review the dilution impact of the 12,159,776 total shares issued on existing shareholders.
- Check for any subsequent filings regarding the specific allocation of the $173.0 million in net proceeds.